Video
Advertise
Newsletter Signup
Podcast
Sign In
Aerospace
AI
Automotive
Cybersecurity
Energy
Gen Z
Industry 4.0
Operations
Software
Supply Chain
Site Map
2010
December
05
Phase III study showed Rituxan/MabThera for initial use followed by continued use delayed need for additional therapy in people with asymptomatic follicular lymphoma, a common...
Page 1 of 1